Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation for Hypertrophic Cardiomyopathy. [PDF]
Neppala S +7 more
europepmc +1 more source
Novel opportunities for the evaluation of vascular function in the cardiac catheterization laboratory [PDF]
Sasi Viktor
core
Chemical myectomy with mavacamten in patients with obstructive hypertrophic cardiomyopathy with prior septal reduction therapy: A single-center experience. [PDF]
Hundal P +7 more
europepmc +1 more source
Delayed Reduction in the Left Ventricular Outflow Tract Gradient After Endocardial Radiofrequency Ablation for Septal Hypertrophy in a Patient With Hypertrophic Obstructive Cardiomyopathy: A Case Report. [PDF]
Chu H +6 more
europepmc +1 more source
Comprehensive improvement in cardiac function following myosin inhibition after the ineffectiveness of myectomy and alcohol septal ablation: a case report. [PDF]
Aleksandrov A +4 more
europepmc +1 more source
Outcomes After Transcatheter Mitral Valve Replacement in Valve in Valve, Valve in Ring, and Mitral Annular Calcification. [PDF]
Nakai C, DeLago A, Samy S.
europepmc +1 more source
Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy. [PDF]
Ibrahim R +9 more
europepmc +1 more source
Combined Endocardial Radiofrequency and Pulsed-Field Left Ventricular Summit Ablation: With Great Power Comes Great Responsibility. [PDF]
Guandalini GS.
europepmc +1 more source
Dual-Modality Focal Ablation for Refractory Ventricular Summit Ectopy: First-in-Human Experience. [PDF]
Prasitlumkum N +4 more
europepmc +1 more source
Fusion imaging with heart navigator for precision-guided alcohol septal ablation in hypertrophic cardiomyopathy. [PDF]
Skowerski M +3 more
europepmc +1 more source

